𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma

✍ Scribed by Hideki Nakasone; Yoshinobu Kanda; Tomoki Ueda; Kenji Matsumoto; Naomi Shimizu; Jiro Minami; Rika Sakai; Maki Hagihara; Akira Yokota; Kumi Oshima; Yuiko Tsukada; Takayoshi Tachibana; Chiaki Nakaseko; Shin Fujisawa; Shingo Yano; Hiroyuki Fujita; Satoshi Takahashi; Heiwa Kanamori; Shinichiro Okamoto

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
105 KB
Volume
84
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Busulfan, cyclophosphamide, and etoposid
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
✍ Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 1 views

## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of high‐dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel

Cerebral and meningeal multiple myeloma
Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature
✍ SΓΈren L. Petersen; Aase Wagner; Peter Gimsing πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 177 KB πŸ‘ 1 views

Meningeal involvement of multiple myeloma is a very rare complication. Defining meningeal myelomatosis (MeM) as the presence of plasma cells in the cerebrospinal fluid in a patient with multiple myeloma, we have found 53 previously reported cases in the literature, where the diagnosis MeM has been m

Autologous stem cell transplantation in
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
✍ Shaji K. Kumar; David Dingli; Martha Q. Lacy; Angela Dispenzieri; Suzanne R. Hay πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

## Abstract High‐dose therapy and autologous stem cell transplant (HDT) have been shown to prolong survival in multiple myeloma (MM) in randomized trials, but only included patients of 65 years or younger. Given the median age at diagnosis of 66 years, it is important to have a better understanding